SAN FRANCISCO, CA, Transcarent announced a $126 million Series D investment led by General Catalyst and 7wireVentures.
Transcarent, the One Place for Health and Care, announced a $126 million Series D investment led by General Catalyst and 7wireVentures, joined by new investors Geodesic Capital and Memorial Hermann Health System, with support from previous investors Threshold Ventures, Kinnevik, Ally Bridge Group, Human Capital, Merck Global Health Innovation Fund, Alta Partners, and Leaps by Bayer.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.